Abstract:Background: Gastric cancer (GC) is the fourth leading cause of cancer-related death worldwide. Minichromsome maintenance proteins family member 8 (MCM8) assists DNA repair and DNA replication. MCM8 exerts tumor promotor function in multiple digestive system tumors. MCM8 is also considered as a potential cancer therapeutic target. Methods: Bioinformatics methods were used to analyze MCM8 expression and clinicopathological significance. MCM8 expression was detected by immunohistochemistry (IHC) staining and qRT-PCR. MCM8 functions in GC cell were explored by Celigo cell counting, colony formation, wound-healing, transwell, and annexin V-APC staining assays. The target of MCM8 was determined by human gene expression profile microarray. Human phospho-kinase array kit evaluated changes in key proteins after ribosomal protein S15A (RPS15A) knockdown. MCM8 functions were reassessed in xenograft mouse model. IHC detected related proteins expression in mouse tumor sections. Results: MCM8 was significantly upregulated and predicted poor prognosis in GC. High expression of MCM8 was positively correlated with lymph node positive (p < 0.001), grade (p < 0.05), AJCC Stage (p < 0.001), pathologic T (p < 0.01), and pathologic N (p < 0.001). MCM8 knockdown inhibited proliferation, migration, and invasion while promoting apoptosis. RPS15A expression decreased significantly after MCM8 knockdown. It was also the only candidate target, which ranked among the top 10 downregulated differentially expressed genes (DEGs) in sh-MCM8 group. RPS15A was identified as the target of MCM8 in GC. MCM8/RPS15A promoted phosphorylation of P38α, LYN, and p70S6K. Moreover, MCM8 knockdown inhibited tumor growth, RPS15A expression, and phosphorylation of P38α, LYN, and p70S6K in vivo. Conclusions: MCM8 is an oncogene and predicts poor prognosis in GC. MCM8/RPS15A facilitates GC progression.

CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma

Aberrant FBXW7-mediated Ubiquitination and Degradation of ZMYND8 Enhances Tumor Progression and Stemness in Bladder Cancer.

FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.

Upregulation of FBXW7 Suppresses Renal Cancer Metastasis and Epithelial Mesenchymal Transition.

CMTM8 inhibits the carcinogenesis and progression of bladder cancer.

E2F8 facilitates malignant phenotypes of muscle-invasive bladder cancer via increasing MCM7 expression

Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase

Cmtm7 Knockdown Increases Tumorigenicity of Human Non-Small Cell Lung Cancer Cells and Egfr-Akt Signaling by Reducing Rab5 Activation

KRT8 upregulation promotes tumor metastasis and is predictive of a poor prognosis in clear cell renal cell carcinoma

The RNF26/CBX7 axis modulates the TNF pathway to promote cell proliferation and regulate sensitivity to TKIs in ccRCC

Frizzled 8 promotes the cell proliferation and metastasis of renal cell carcinoma.

Knockdown of MCM8 inhibits development and progression of bladder cancer in vitro and in vivo

SCF‐FBXL8 Contributes to Liver Metastasis and Stem‐cell‐like Features in Colorectal Cancer Cells by Mediating Ubiquitination and Degradation of TP53

MCM8 promotes gastric cancer progression through RPS15A and predicts poor prognosis

Function and mechanism of MCM8 in the development and progression of colorectal cancer

Down-regulation of CMTM8 Induces Epithelial-to-Mesenchymal Transition-like Changes Via C-Met/extracellular Signal-regulated Kinase (ERK) Signaling*

Cancer-Associated Fibroblast-Derived FGF7 Promotes Clear Cell Renal Cell Carcinoma Progression and Macrophage Infiltration

CDK4/6 inhibitors dephosphorylate RNF26 to stabilize TSC1 and increase the sensitivity of ccRCC to mTOR inhibitors

Fbxo22 promotes cervical cancer progression via targeting p57Kip2 for ubiquitination and degradation

FBW7 Suppresses Cell Proliferation and G2/M Cell Cycle Transition Via Promoting Γ-Catenin K63-linked Ubiquitylation.

DNMT1-maintained Hypermethylation of Krüppel-like Factor 5 Involves in the Progression of Clear Cell Renal Cell Carcinoma